These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29021137)

  • 21. Commonly observed RNF43 mutations retain functionality in attenuating Wnt/β-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers.
    Li S; Lavrijsen M; Bakker A; Magierowski M; Magierowska K; Liu P; Wang W; Peppelenbosch MP; Smits R
    Oncogene; 2020 Apr; 39(17):3458-3472. PubMed ID: 32103169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
    Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M
    J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis.
    Bond CE; McKeone DM; Kalimutho M; Bettington ML; Pearson SA; Dumenil TD; Wockner LF; Burge M; Leggett BA; Whitehall VL
    Oncotarget; 2016 Oct; 7(43):70589-70600. PubMed ID: 27661107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of β-catenin signalling promotes DNA damage elicited by benzo[a]pyrene in a model of human colon cancer cells via CYP1 deregulation.
    Kabátková M; Zapletal O; Tylichová Z; Neča J; Machala M; Milcová A; Topinka J; Kozubík A; Vondráček J
    Mutagenesis; 2015 Jul; 30(4):565-76. PubMed ID: 25805023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2.
    Zhang Y; Lin C; Liao G; Liu S; Ding J; Tang F; Wang Z; Liang X; Li B; Wei Y; Huang Q; Li X; Tang B
    Oncotarget; 2015 Oct; 6(32):32586-601. PubMed ID: 26452129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
    Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner.
    Hao HX; Xie Y; Zhang Y; Charlat O; Oster E; Avello M; Lei H; Mickanin C; Liu D; Ruffner H; Mao X; Ma Q; Zamponi R; Bouwmeester T; Finan PM; Kirschner MW; Porter JA; Serluca FC; Cong F
    Nature; 2012 Apr; 485(7397):195-200. PubMed ID: 22575959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-proliferative activity of hydnocarpin, a natural lignan, is associated with the suppression of Wnt/β-catenin signaling pathway in colon cancer cells.
    Lee MA; Kim WK; Park HJ; Kang SS; Lee SK
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5511-4. PubMed ID: 24018191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
    Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
    Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.
    Buchert M; Rohde F; Eissmann M; Tebbutt N; Williams B; Tan CW; Owen A; Hirokawa Y; Gnann A; Orend G; Orner G; Dashwood RH; Heath JK; Ernst M; Janssen KP
    Dis Model Mech; 2015 Nov; 8(11):1361-73. PubMed ID: 26398937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator.
    Wang S; Bao Z; Liang QM; Long JW; Xiao ZS; Jiang ZJ; Liu B; Yang J; Long ZX
    Hepatogastroenterology; 2013 Oct; 60(127):1639-46. PubMed ID: 24634935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor Suppressive Role of ARHGAP17 in Colon Cancer Through Wnt/β-Catenin Signaling.
    Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
    Cell Physiol Biochem; 2018; 46(5):2138-2148. PubMed ID: 29730655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisleuconothine A, a bisindole alkaloid, inhibits colorectal cancer cell in vitro and in vivo targeting Wnt signaling.
    Kong LM; Feng T; Wang YY; Li XY; Ye ZN; An T; Qing C; Luo XD; Li Y
    Oncotarget; 2016 Mar; 7(9):10203-14. PubMed ID: 26862734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Issues with RNF43 antibodies to reliably detect intracellular location.
    Li S; Zhang R; Lavrijsen M; van den Bosch TPP; Peppelenbosch MP; Smits R
    PLoS One; 2023; 18(4):e0283894. PubMed ID: 37023034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis.
    Tu J; Park S; Yu W; Zhang S; Wu L; Carmon K; Liu QJ
    Sci Rep; 2019 Dec; 9(1):18557. PubMed ID: 31811196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secreted pyruvate kinase M2 facilitates cell migration via PI3K/Akt and Wnt/β-catenin pathway in colon cancer cells.
    Yang P; Li Z; Wang Y; Zhang L; Wu H; Li Z
    Biochem Biophys Res Commun; 2015 Apr; 459(2):327-332. PubMed ID: 25732087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.
    Shitashige M; Naishiro Y; Idogawa M; Honda K; Ono M; Hirohashi S; Yamada T
    Gastroenterology; 2007 Mar; 132(3):1039-54. PubMed ID: 17383426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-93 suppress colorectal cancer development via Wnt/β-catenin pathway downregulating.
    Tang Q; Zou Z; Zou C; Zhang Q; Huang R; Guan X; Li Q; Han Z; Wang D; Wei H; Gao X; Wang X
    Tumour Biol; 2015 Mar; 36(3):1701-10. PubMed ID: 25371073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling.
    Kang DW; Lee BH; Suh YA; Choi YS; Jang SJ; Kim YM; Choi KY; Min DS
    Clin Cancer Res; 2017 Dec; 23(23):7340-7350. PubMed ID: 28939743
    [No Abstract]   [Full Text] [Related]  

  • 40. DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.
    Roy N; Bommi PV; Bhat UG; Bhattacharjee S; Elangovan I; Li J; Patra KC; Kopanja D; Blunier A; Benya R; Bagchi S; Raychaudhuri P
    Cancer Res; 2013 Jun; 73(12):3771-82. PubMed ID: 23610444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.